Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmaceutics
|
September 27, 2025
Selenium Nanoparticles: Synthesis, Stability and In Vitro Evaluation in Human Lens Epithelial Cells
Lulwah Al-Bassam, Mohammed M Naiyer, Christopher J Morris, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2013
A peptide antagonist disrupts NK cell inhibitory synapse formation
Gwenoline Borhis, Parvin S Ahmed, Bérénice Mbiribindi, et al.
Medical Oncology (Northwood, London, England)
|
September 6, 2025
The microbiome-cancer axis as a hidden contributor to early-onset tumorigenesis
Azfar Jamal, Mohammad Azhar Kamal, Yaser E Alqurashi, et al.
Pathology, Research and Practice
|
March 15, 2026
Interpreting the ubiquitin signal: Deubiquitinating enzymes in cancer and disease
Azfar Jamal, Pooja Kaushik, Atahar Husein, et al.
HLA
|
November 2, 2018
A novel antibody combination to identify KIR2DS2<sup>high</sup> natural killer cells in KIR2DL3/L2/S2 heterozygous donors
Matthew D Blunt, Pauline Rettman, Leidy Y Bastidas-Legarda, et al.
Cancer Gene Therapy
|
June 13, 2026
Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities
Atahar Husein, Azfar Jamal, Mohammad Azhar Kamal, et al.
Current Pharmaceutical Design
|
March 25, 2026
Ubiquitin in Human Diseases: Pathophysiology, Dysfunction and Treatment
Azfar Jamal, Atahar Husein, Mohammad Azhar Kamal, et al.
Cell Biology International
|
August 21, 2024
Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis
Sulieman I Shelash Al-Hawary, Farag M A Altalbawy, Saade Abdalkareem Jasim, et al.
Journal of Viral Hepatitis
|
February 1, 2019
Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
Hariklia Kranidioti, Spilios Manolakopoulos, George Kontos, et al.
Science Immunology
|
September 17, 2017
KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C
Mohammed M Naiyer, Sorcha A Cassidy, Andrea Magri, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmaceutics
|
September 27, 2025
Selenium Nanoparticles: Synthesis, Stability and In Vitro Evaluation in Human Lens Epithelial Cells
Lulwah Al-Bassam, Mohammed M Naiyer, Christopher J Morris, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2013
A peptide antagonist disrupts NK cell inhibitory synapse formation
Gwenoline Borhis, Parvin S Ahmed, Bérénice Mbiribindi, et al.
Medical Oncology (Northwood, London, England)
|
September 6, 2025
The microbiome-cancer axis as a hidden contributor to early-onset tumorigenesis
Azfar Jamal, Mohammad Azhar Kamal, Yaser E Alqurashi, et al.
Pathology, Research and Practice
|
March 15, 2026
Interpreting the ubiquitin signal: Deubiquitinating enzymes in cancer and disease
Azfar Jamal, Pooja Kaushik, Atahar Husein, et al.
HLA
|
November 2, 2018
A novel antibody combination to identify KIR2DS2<sup>high</sup> natural killer cells in KIR2DL3/L2/S2 heterozygous donors
Matthew D Blunt, Pauline Rettman, Leidy Y Bastidas-Legarda, et al.
Cancer Gene Therapy
|
June 13, 2026
Hepatitis B virus-induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities
Atahar Husein, Azfar Jamal, Mohammad Azhar Kamal, et al.
Current Pharmaceutical Design
|
March 25, 2026
Ubiquitin in Human Diseases: Pathophysiology, Dysfunction and Treatment
Azfar Jamal, Atahar Husein, Mohammad Azhar Kamal, et al.
Cell Biology International
|
August 21, 2024
Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis
Sulieman I Shelash Al-Hawary, Farag M A Altalbawy, Saade Abdalkareem Jasim, et al.
Journal of Viral Hepatitis
|
February 1, 2019
Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
Hariklia Kranidioti, Spilios Manolakopoulos, George Kontos, et al.
Science Immunology
|
September 17, 2017
KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C
Mohammed M Naiyer, Sorcha A Cassidy, Andrea Magri, et al.
Page
of 1